Invention Grant
- Patent Title: Anti-CD40 antibodies capable of blocking B-cell activation
- Patent Title (中): 能够阻断B细胞活化的抗CD40抗体
-
Application No.: US12049850Application Date: 2008-03-17
-
Publication No.: US07790166B2Publication Date: 2010-09-07
- Inventor: Mark de Boer , Leah B. Conroy
- Applicant: Mark de Boer , Leah B. Conroy
- Applicant Address: US CA Emeryville
- Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee Address: US CA Emeryville
- Agent Leslie T. Henry; Lisa E. Alexander
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; C12N5/12 ; A61K39/44

Abstract:
Methods for preventing or treating an antibody-mediated disease in a patient are presented, the methods comprising administration of a monoclonal antibody capable of binding to a human CD40 antigen located on the surface of a human B cell, wherein the binding of the antibody to the CD40 antigen prevents the growth or differentiation of the B cell. Monoclonal antibodies useful in these methods, and epitopes immunoreactive with such monoclonal antibodies are also presented.
Public/Granted literature
- US20090130095A1 ANTI-CD40 ANTIBODIES CAPABLE OF BLOCKING B-CELL ACTIVATION Public/Granted day:2009-05-21
Information query